- Alternative title
-
Neuartige Therapien Strategien für Cisplatin-resistenten Blasenkrebs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2019
- Keyword
-
Cisplatin
Bladder--Cancer
- Event
-
Veröffentlichung
- (where)
-
Düsseldorf
- (who)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (when)
-
2020
- Creator
- URN
-
urn:nbn:de:hbz:061-20200512-112836-5
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Chenyin
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Time of origin
- 2020
Other Objects (12)
New approaches for cisplatin-resistant bladder cancer
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
In vitro studies on the influence of Sulforaphane on human cisplatin and gemcitabine-resistant bladder carcinoma cells
Artesunate impairs growth in cisplatin-resistant bladder cancer cells by cell cycle arrest, apoptosis and autophagy induction
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Predicting clinically promising therapeutic hypotheses using tensor factorization
Promising therapeutic aspects in human genetic imprinting disorders
New approaches for cisplatin-resistant bladder cancer
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
In vitro studies on the influence of Sulforaphane on human cisplatin and gemcitabine-resistant bladder carcinoma cells
Artesunate impairs growth in cisplatin-resistant bladder cancer cells by cell cycle arrest, apoptosis and autophagy induction
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Predicting clinically promising therapeutic hypotheses using tensor factorization
Promising therapeutic aspects in human genetic imprinting disorders
New approaches for cisplatin-resistant bladder cancer
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
In vitro studies on the influence of Sulforaphane on human cisplatin and gemcitabine-resistant bladder carcinoma cells
Artesunate impairs growth in cisplatin-resistant bladder cancer cells by cell cycle arrest, apoptosis and autophagy induction
Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate
Inflammasome inhibitors: promising therapeutic approaches against cancer
RFX1: a promising therapeutic arsenal against cancer
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Predicting clinically promising therapeutic hypotheses using tensor factorization